SCIENCE 37
About Science 37
SCIENCE 37
About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. As a single Metasite™ Science 37 reaches an expanded patient population beyond the traditional site and delivers the recruiting power of up to 20 sites in one with greater patient diversity. Patients gain the flexibility to participate from the comfort of their own home, at their local community provider, or at a traditional site when needed.
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. As a single Metasite™ Science 37 reaches an expanded patient population beyond the traditional site and delivers the recruiting power of up to 20 sites in one with greater patient diversity. Patients gain the flexibility to participate from the comfort of their own home, at their local community provider, or at a traditional site when needed.

Metasite - The Science 37 Virtual Site
Science 37 expands clinical trial access regardless of location, with the flexibility of the Metasite, supporting patients from the comfort of home, at their local community provider, or at a research site.
Contact us today to learn more about how we can help you.
Metasite - The Science 37 Virtual Site
Science 37 expands clinical trial access regardless of location, with the flexibility of the Metasite, supporting patients from the comfort of home, at their local community provider, or at a research site.
Contact us today to learn more about how we can help you.
